Site Search
Professionals 97 results
Capabilities 51 results
Industry
Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry.
Industry
Winston’s financial crimes compliance lawyers have been providing regulatory compliance counseling and enforcement services related to the Bank Secrecy Act (BSA), the Anti-Money Laundering Act of 2020 (AML), and countering the financing of terrorism (CFT) policy for decades. We also have experience with international AML matters, including in the EU and with respect to Financial Actions Task Force (FATF) recommendations.
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Experience 16 results
Experience
|April 30, 2025
In December 2022, Winston convinced Judge Albright of the W.D. Tex. to reverse his tentative construction and invalidate four patents based on means-plus-function indefiniteness at claim construction in the district court. Winston also persuaded Judge Albright to deny Fintiv’s motion for reconsideration the next month. Fintiv appealed to the Federal Circuit, which affirmed the district court in a precedential opinion in April 2025. Winston overcame a significant amount of sleight of hand from Fintiv, which continually shifted the purported structure of the “payment handler” term through claim construction, its motion for reconsideration, and appellate briefs, muddying the record. Ultimately the opinion clearly distinguished the factual record from that in Dyfan v. Target, curbing patentees abilities to argue that all code or applications are a “class of structures” and not indefinite under 112(f). The Federal Circuit affirmed four of the five patents Winston invalidated for PayPal, effectively foreclosing Fintiv’s ability to revive these patents for assertion. Winston also invalidated the fifth patent at the PTAB; Fintiv’s appeal of that Final Written Decision is pending.
Experience
|March 18, 2025
Winston Blunts Earnout Payment
Following a bench trial in Fall 2024, a New York trial court ruled in March 2025 that Cresco Labs, Inc. was not required to pay a US$45M earnout under a merger agreement. The court found that Cresco did not receive “commercially reasonable access” to New York’s adult-use cannabis market, which was supposed to be subject only to a non-competitive application or approval process. Adopting Cresco’s arguments, the court determined that only the Office of Cannabis Management and Cannabis Control Board could decide when and how applicants access the adult-use market. The court agreed that regulators required Cresco to pay a significant one-time fee, prioritized other applicants, and had broad discretion over approvals. This win supports claims that New York’s adult-use program lacks details and clear entry paths, frustrating industry leaders’ efforts to develop a robust adult-use market.
Experience
|September 27, 2024
Winston Represents KeHE Distributors, LLC in a $250.0 Million Senior Secured Notes Tack-On Offering
Winston represented KeHE Distributors, LLC in connection with a Rule 144A/Reg. S tack-on offering of $250,000,000 aggregate principal amount of 9.000% senior secured notes due 2029 issued by KeHE Distributors, LLC, NextWave Distribution, Inc. and KeHE Finance Corp. Proceeds from the offering were used to partially pay down existing ABL borrowings. KeHE Distributors, LLC is a leading pure-play natural and organic, specialty and fresh products food distributor in North America.
Insights & News 1,303 results
In the Media
|January 8, 2026
|1 Min Read
Bobby Malhotra Shares Predictions for eDiscovery in 2026 with LegalTech News
Winston & Strawn partner Bobby Malhotra was featured in a LegalTech News article where legal professionals share their insights for what is in store for the e-discovery industry in 2026. Bobby shared that he believes AI transcription rollouts will drive a surge in privacy-based wiretap litigation in 2026.
In the Media
|January 7, 2026
|1 Min Read
Winston Paris Partners’ Healthcare Roundtable Featured in Décideurs Magazine
In a context of structural strain on the French healthcare system—marked by social security deficits, pressure on hospitals, shortages of healthcare professionals, and territorial inequalities in access to care—the role of private investment in the healthcare sector is the subject of growing debate.
Article
|January 6, 2026
|5 Min Read
Guardrails Before Greenlights: How Gen AI Will Actually Shape E-discovery in 2026
This article was originally published in LegalTech News. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only.
Other Results 34 results
Site Content
Site Content
Anti-Money Laundering (AML) refers to policies and practices that prevent, detect, and report financial crimes. The principal U.S. federal law on money laundering is the Bank Secrecy Act (BSA), also known as the Currency and Foreign Transactions Reporting Act of 1970. The BSA generally mandates financial institutions to assist in governmental investigations by keeping records of cash purchases or negotiable instruments, filing reports of cash transactions exceeding a set daily aggregate amount, and reporting suspicious activity that may hint at money laundering, tax evasion, or other criminal activities.
Site Content
Tax evasion is the failure to pay or the deliberate underpayment of federal income taxes. The U.S. income tax system is based on voluntary compliance, and it is the taxpayer’s responsibility to report all income and to pay all taxes due. Tax evasion is a known violation of a legal duty, and may result in monetary penalties, imprisonment, or both.